Number 34
Indolent prostate cancer and active surveillance
Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this? Download full article
Ten years reporting from the front line
Rabiya Tuma won a Best Cancer Reporter Award for her contributions to The Economist. Here her article highlights some of the growing evidence about the role of stem cells in cancer. Download full article